Vaccination News

A decrease in cervical cancer rates in the United States, most notably among younger women, may be associated with HPV vaccination approval, according to a retrospective, cross-sectional study published in JAMA Network Open.

Moderna’s COVID-19 vaccine was found to be safe and effective among children aged 6 to 11 years, according to interim phase 2/3 findings from the KidCOVE trial published in The New England Journal of Medicine.

The FDA has restricted the use of Johnson & Johnson’s COVID-19 vaccine due to its association with thrombosis with thrombocytopenia syndrome.

SAN DIEGO — Pregnant patients who had more knowledge about COVID-19 and immunization were more likely to get vaccinated against SARS-CoV-2, according to a study presented here.

The FDA has restricted the use of Johnson & Johnson’s COVID-19 vaccine based on an updated analysis of the risk for a rare but potentially deadly blood-clotting syndrome.

An investigational COVID-19 vaccine developed by City of Hope induced a robust immune response against SARS-CoV-2, according to results of a phase 1 clinical trial.

Women with COVID-19 during pregnancy who subsequently received one mRNA vaccine dose had the highest levels of antibodies at delivery compared with infected, unvaccinated women and vaccinated women who were never infected.

Since 2020, COVID-19 has persisted as the third-leading cause of death in the United States.

The top stories in infectious disease last week focused on research that was recently presented at the European Congress of Clinical Microbiology and Infectious Diseases in Lisbon, Portugal.

Researchers estimated that more than 200 million people globally suffer from long-term effects of COVID-19, according to a recent study.